Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 12

Results: 22
    1
    2
    3
    4
    5
    6
    7

    Top advances of the year: Breast cancer.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1791, doi. 10.1002/cncr.34752
    By:
    • Saavedra, Cristina;
    • Gion, María;
    • Cortés, Javier;
    • Llombart‐Cussac, Antonio
    Publication type:
    Article
    8
    9

    Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1836, doi. 10.1002/cncr.34750
    By:
    • Weiss, Anna;
    • Martínez‐Sáez, Olga;
    • Waks, Adrienne G.;
    • Laws, Alison;
    • McGrath, Monica;
    • Tarantino, Paolo;
    • Portnow, Leah;
    • Winer, Eric;
    • Rey, María;
    • Tapia, Marta;
    • Prat, Aleix;
    • Partridge, Ann H.;
    • Tolaney, Sara M.;
    • Cejalvo, Juan M.;
    • Mittendorf, Elizabeth A.;
    • King, Tari A.
    Publication type:
    Article
    10
    11

    The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1885, doi. 10.1002/cncr.34742
    By:
    • Lev‐Ari, Shaked;
    • Serzan, Michael;
    • Wu, Tianmin;
    • Ip, Andrew;
    • Pascual, Lauren;
    • Sinclaire, Brittany;
    • Adams, Shari;
    • Marafelias, Michael;
    • Ayyagari, Lakshmi;
    • Gill, Sarvarinder K.;
    • Ma, Barbara;
    • Zaemes, Jacob P.;
    • Della Pia, Alexandra;
    • Alaoui, Adil;
    • Madhavan, Subha;
    • Belouali, Anas;
    • Pecora, Andrew;
    • Ahn, Jaeil;
    • Atkins, Michael B.;
    • Shah, Neil J.
    Publication type:
    Article
    12
    13
    14

    Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1904, doi. 10.1002/cncr.34730
    By:
    • Mooradian, Meghan J.;
    • Cleary, James M.;
    • Giobbie‐Hurder, Anita;
    • Darville, Lancia N. F.;
    • Parikh, Aparna;
    • Buchbinder, Elizabeth I.;
    • Cohen, Justine V.;
    • Lawrence, Donald P.;
    • Shapiro, Geoffrey I.;
    • Keer, Harold;
    • Chen, Helen X.;
    • Ivy, Susan Percy;
    • Smalley, Keiran S. M.;
    • Koomen, John M.;
    • Sullivan, Ryan J.
    Publication type:
    Article
    15
    16

    Association between bariatric surgery and outcomes in chronic myeloid leukemia.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1866, doi. 10.1002/cncr.34725
    By:
    • Haddad, Fadi G.;
    • Kantarjian, Hagop M.;
    • Bidikian, Aram;
    • Jabbour, Elias J.;
    • Short, Nicholas J.;
    • Ning, Jing;
    • Xiao, Lianchun;
    • Pemmaraju, Naveen;
    • DiNardo, Courtney D.;
    • Kadia, Tapan M.;
    • Marx, Kayleigh R.;
    • Garcia‐Manero, Guillermo;
    • Ravandi, Farhad;
    • Sasaki, Koji;
    • Issa, Ghayas C.
    Publication type:
    Article
    17
    18

    Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1856, doi. 10.1002/cncr.34728
    By:
    • Nguyen, Daniel;
    • Kantarjian, Hagop M.;
    • Short, Nicholas J.;
    • Qiao, Wei;
    • Ning, Jing;
    • Cuglievan, Branko;
    • Daver, Naval G.;
    • DiNardo, Courtney D.;
    • Jabbour, Elias J.;
    • Kadia, Tapan M.;
    • Borthakur, Gautam;
    • Garcia‐Manero, Guillermo;
    • Konopleva, Marina Y.;
    • Andreeff, Michael;
    • Ravandi‐Kashani, Farhad;
    • Sasaki, Koji;
    • Issa, Ghayas C.
    Publication type:
    Article
    19
    20

    Issue Information.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1781, doi. 10.1002/cncr.33715
    Publication type:
    Article
    21

    Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1846, doi. 10.1002/cncr.34706
    By:
    • Mirza, Mansoor R.;
    • González‐Martín, Antonio;
    • Graybill, Whitney S.;
    • O'Malley, David M.;
    • Gaba, Lydia;
    • Stephanie Yap, Oi Wah;
    • Guerra, Eva M.;
    • Rose, Peter G.;
    • Baurain, Jean‐François;
    • Ghamande, Sharad A.;
    • Denys, Hannelore;
    • Prendergast, Emily;
    • Pisano, Carmela;
    • Follana, Philippe;
    • Baumann, Klaus;
    • Calvert, Paula M.;
    • Korach, Jacob;
    • Li, Yong;
    • Malinowska, Izabela A.;
    • Gupta, Divya
    Publication type:
    Article
    22